St. Louis, MO 的 腎臟癌 臨床試驗
9 項針對 腎臟癌 的研究正在 St. Louis（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
招募中1 期
- Washington University School of Medicine, St Louis
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
招募中1/2 期
- Washington University in St. Louis, St Louis
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
招募中3 期
- Research Site, St Louis
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
招募中觀察性研究
- Washington University, St Louis
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
招募中1/2 期
- Siteman Cancer Center, St Louis
- Barnes-Jewish Hospital, St Louis
- Washington University School of Medicine - Siteman Cancer Center, St Louis
- 還有 5 項
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
招募中觀察性研究
- Mercy Hospital - South, St Louis
- Mercy Hospital -STL, St Louis
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
招募中1 期
- Washington University School of Medicine, St Louis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, St Louis
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
招募中1/2 期
- Washington University, St Louis
其他城市的 腎臟癌 試驗
- New York City, NY15 項研究
- Nashville, TN12 項研究
- Boston, MA12 項研究
- Houston, TX10 項研究
- San Diego, CA9 項研究
- Washington, DC9 項研究
- Dallas, TX9 項研究
- Seattle, WA8 項研究
- Edison, NJ8 項研究
- Miami, FL8 項研究
- Los Angeles, CA7 項研究
- Baltimore, MD7 項研究
St. Louis 的其他研究
- 非小細胞肺癌73 項研究
- 乳癌65 項研究
- 轉移性癌症54 項研究
- 大腸直腸癌51 項研究
- 癌症（所有類型）47 項研究
- 前列腺癌46 項研究
- 肺癌39 項研究
- 卵巢癌38 項研究
- 胰臟癌33 項研究
- 子宮內膜癌29 項研究
- 頭頸部鱗狀細胞癌28 項研究
- 心臟衰竭26 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月7日。各研究自行設定資格標準；由研究團隊決定參與者資格。